维普中文期刊产品整合服务
19篇 您的检索式:作者名="Rahmanto"
    题名 作者 年代 出处 被引量
1lronuptake and metabolism in the new millennium 显示文摘Louise L Dunn Yohan Suryo Rahmanto Des R Richardson 2006Trends in Cell Biology2006,17,2:1
2Iron uptake and metabolism in the new millennium 显示文摘Durra LL Rahmanto YS Richardson DR 2007Trends Cell Biol2007,17,:1
3Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein-E discs and suppression of amy- loid-beta peptide generation 显示文摘Kim WS Rahmanto AS Kamili A 2007J Biol Chem2007,282,5:1
4N-myc downstream regulated 1 ( NDRG1 ) is regulated by eukaryotic initiation factor 3a (eIF3a) during Cellular stress caused by iron depletion显示文摘Lane DJ Saletta F Suryo Rahmanto Y 2013PloS One2013,8,57:1
5Cellular Iron depletion and the mechanisms involved in the iron-dependent regulation of the growth arrest and DNA damage family of genes显示文摘Saletta F Suryo Rahmanto Y Siafakas AR Richardson DR 2011J Biol Chem2011,286,35:1
6Iron Chelators for the Treatment of Cancer显示文摘Y. Yu E. Gutierrez Z. Kovacevic F. Saletta P. Obeidy Y. Suryo Rahmanto D. R. Richardson 2012Current Medicinal Chemistry2012,,17:1
7IRON uptake and metabolism in the new millennium 显示文摘DUNN LL RAHMANTO YS RICHARDSON DR 2007Trends Cell Biol2007,17,2:1
8Iron chelator-mediated alterations in gene expression:identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53显示文摘Saletta F Suryo Rahmanto Y Noulsri E 0,,03:1
9Role of ABCG1 and ABCA 1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation显示文摘Kim WS Rahmanto AS Kamili A 2007J Biol Chem2007,282,5:1
10The translational regulator eIF3a: the tricky elF3 subunit显示文摘Saletta F Rahmanto YS Richardson DR 2010Biochim Biophys Acta2010,1806,2:1
11Iron uptake and metabo- lism in the new millennium 显示文摘Dunn L L Rahmanto Y S Richardson D R 2007Trends Cell Biol2007,17,:1
12Iron uptake and melabolism in the new millennium显示文摘Dunn LL Rahmanto YS Richardson DR 2007Trends Cell Biol2007,17,2:1
13N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion 显示文摘Lane DJ Saletta F Suryo Rahmanto Y 2013PLoS One2013,8,57:1
14Cellular effects of peptide and protein hydroperoxides 显示文摘Rahmanto A S Morgan P E Hawkins C L 2010Free Radical Biology & Medicine2010,48,:1
15Iron uptake and metabolism in the new millennium显示文摘Dunn LL Rahmanto Y Richardson DR 2007Trends Cell Biol2007,17,2:1
16Iron uptake and metabolism in the new millennium 显示文摘Louise L Dunn Yohan Suryo Rahmanto Des R Richardson 2006Trends in Cell Biology2006,17,2:1
17Cellular Iron depletion and the mechanisms involved in the iron-dependent regulation of the growth arrest and DNA damage family of genes显示文摘Saletta F Suryo Rahmanto Y Siafakas AR Richardson DR 2011J Biol Chem2011,286,35:1
18The translational regulator eIF3a: The tricky elF3 subunit! 显示文摘Saletta F Rahmanto YS Richardson DR 2010Biochimica et Biophysica Acta (BBA) - Reviews on Cancer2010,1806,2:1
19Relationship between ovarian cancer stem cells,epithelial mesenchymal transition and tumour recurrence显示文摘Investigating the biological processes that occur to enable recurrence and the development of chemoresistance in ovarian cancer is critical to the research and development of improved treatment options for patients.The lethality of ovarian cancer is largely attributed to the recurrence of disease with acquired chemoresistance.Cancer stem cells are likely to be critical in ovarian cancer progression,contributing to tumour malignancy,metastasis and recurrence by persisting in the body despite treatment with anti-cancer drugs.Moreover,cancer stem cells are capable of mediating epithelial-to-mesenchymal transition traits and secrete extracellular vesicles to acquire therapy resistance and disease dissemination.These attributes merit in depth research to provide insight into the biological role of ovarian cancer stem cells in disease progression and chemotherapy response,leading to the development of improved biomarkers and innovative therapeutic approaches.Monica Angelica Amaya Padilla Mudra Binju Graeme Wan Yohan Suryo Rahmanto Pritinder Kaur Yu Yu 2019Cancer Drug Resistance2019,2,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费